CMR Surgical revealed that it’s an early adopter of NVIDIA IGXThor as it assesses its integration into the company’s Versius surgical system.

IGX Thor is NVIDIA’s latest, most powerful platform for physical artificial intelligence (AI) and robotics. It delivers up to 5,581 FP4 TFLOPS of AI compute with 400 GBe of connectivity, providing more compute power, better energy efficiency, and awareness compared to prior platforms.

CMR hopes to leverage its data with AI for insights and recommendations in real time, at the point of care. The company aims to enable data captured from every Versius procedure to improve all surgeries.

The company said it will evaluate IGX Thor’s AI capabilities for the next generation of Versius and bring intelligent surgical support to enhance surgeons’ capabilities and democratize minimally invasive surgery. Versius captures telematic, video, and outcome data through its digital ecosystem to provide meaningful insights.

The surgical robot was designed to seamlessly, easily integrate into any operating room and hospital workflow. The system has performed about 40,000 surgical cases to date and is being used in urology, general surgery, gynecology, and thoracic surgery.

“Today’s announcement reflects our strategic intent in leveraging the formidable potential of AI and represents a further step forward in our mission to deliver real-time insights that improve outcomes,” said CMR Surgical chief technology officer Chris Fryer. “The goal of AI isn’t to replace surgeons, but to empower them. We’re excited to explore how NVIDIA IGX Thor can revolutionise the AI capabilities within the Versius ecosystem and look forward to continuing to work closely with the NVIDIA team.”

The Versius surgical robot earned U.S. Food and Drug Administration (FDA) clearance in October 2024.